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Abstract
Aims To evaluate the long-term outcome and quality of
life (QoL) data, and to assess the potential influence of age
and different conservative procedures on laparoscopic
surgery.
Background Current therapies for achalasia can palliate
dysphagia, but other symptoms may persist, making it
difficult to quantify and compare. To understand if they
could influence results, we analized short- and long-term
results and correlated them to age and previous conserva-
tive treatments using a specific QoL test.
Methods Functional examinations (endoscopy, 24-hr pH
manometry, upper GI X-rays) and the gastrointestinal
quality of life index (GIQLI) were used before and after a
laparoscopic Heller–Dor myotomy. Data were analyzed by
the Mann–Whitney U test, Wilcoxon signed rank test, and
Spearman’s q coefficient for bivariate correlations
(p < 0.05).
Results From January 1996 to January 2004, 31 consec-
utive patients out of 35 diagnosed with achalasia, in
clinical stages I–III, were operated on by laparoscopy .
Two groups were identified using the break point of 70
years of age, (20 younger and 15 older) and two subgroups
according to the conservative therapy performed (20, none;
15, some). Patients underwent a clinical manometry eval-
uation at six and 12 months, and then yearly, and pH-metry
at six, 24, and 60 months. In 78% of patients dysphagia
disappeared and the incidence of reflux was 13%. Age and
previous treatments did not influence surgical outcome.
Patients completed a GIQLI questionnaire before surgery,
six months after surgery, and then yearly (for five years).
The median preoperative GIQLI score was 78 (range 38–
109) out of a theoretical maximum score of 144. At a
median follow-up of 49 months (range 24–72 months), the
score had significantly improved to 115 (range 71–140).
There was no significant statistical difference between the
groups.
Conclusions Laparoscopic Heller–Dor myotomy is an
effective palliation for achalasia; the long-term outcome is
not significantly affected by preoperative conservative
treatments or by the age of the patients. The GIQLI
questionnaire is a reliable instrument to compare the
impact of achalasia symptoms on health-related QoL
before and after surgery.
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Oesophageal achalasia is a motor disorder caused by an
irreversible degeneration of the oesophageal myenteric
plexus, with an estimated annual incidence of 1/100,000
individuals in Western countries. It is characterized by
aperistalsis or uncoordinated contractions of the body and
impaired relaxation of a frequently manometrically hyper-
tensive lower sphincter (LES). The therapeutic procedures
tend to the palliation of dysphagia and other symptoms
caused by the stasis as no available treatment can restore the
motility or the coordination of the oesophagus. According to
the only prospective, randomized trial by Csendes et al.
(1989) [1] comparing the long-term results of the pneumatic
dilation and oesophagomyotomy, the procedure of choice for
idiopathic achalasia should be surgical myotomy of the LES,
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as initially reported by Heller in 1913, with some modifi-
cations. Until the beginning of 1990 the approaches were
laparotomy or thoracotomy, with overall good long-term
results in about 80% of patients, but with a perceived rela-
tively high morbidity associated with open surgical
treatment that led to most patients and physicians favouring
endoscopic dilation as the primary conservative option for
achalasia. More recently several nonrandomized studies
showed conclusively that the mini-invasive approaches,
mainly laparoscopic, are associated with shorter operative
time and hospitalization, lower morbidity, and lower inci-
dence of postoperative reflux [2–3]. Compiled series of
laparoscopic myotomies noted the improvement of symp-
toms in 85 to 100% of patients, showing very low rates of
morbidity and mortality. The incidence of symptomatic
reflux disease (GERD) was 0 to 18%, as shown in both series
with a relatively short follow-up (average < 2 years) [4–5],
and longer than six years [6]. Moreover it has been shown
that prior use of botulinum toxin and oesophageal dilation,
often in sequence, can induce fibrosis of the submucosa,
leading to a more-difficult and longer mini-invasive proce-
dure with a higher risk of intraoperative perforation but
without a negative impact on long-term outcome [7]. These
satisfying outcomes, however, led to the more frequent
choice of surgery as the primary treatment [5].
This study analyzes the short- and long-term surgical
and health-related QoL outcomes of laparoscopic Heller–
Dor myotomy, looking at the influence of the age of the
patients and of previous conservative treatments on post-
operative outcome.
Patients and methods
A consecutive series of 35 patients with the diagnosis of
achalasia and a median preoperative duration of symptoms
of 42 months (range 6–180 months) who underwent treat-
ment from January 1996 to January 2004 at our institution
were analyzed. There were 21 women and 14 men with a
mean age of 43 years (28–82); 15 of them were older than 70
years. All of them complained of dysphagia, 24 patients of
regurgitation (68.6%), 10 patients of heartburn (28.6%), nine
patients of chest pain (25.7%), five patients of upper
abdominal pain (14.3%), and 10 patients of varying degrees
of respiratory symptoms (28.6%). All patients underwent
preoperative upper GI endoscopy, contrast radiographs,
oesophageal manometry and pH-metry, and were scored
with the gastro-intestinal quality of life index (GIQLI).
Patients were distributed in two groups: those under 70
years old (group A, 20 patients) and those over 70 years-
old (group B, 15 patients), and each group was then split
into two subgroups depending on whether conservative
therapies were performed or not (Table 1).
Four patients (3A–1B) (11.4%) had normal or mild (<4
cm) oesophageal dilation (stage 1), 13 patients (8/A–5/B)
(37.1%) had moderate (4–6 cm) oesophageal dilation
(stage 2), 17 patients (9/A–8/B) (48.6%) had stage 3 dila-
tion (>6 cm), and one patient (group B) (2.9%) had a stage
4 sigmoid-shaped oesophagus. A hiatal hernia was present
in two patients (one patient stage 2 and one at stage 3 of
oesophageal dilation), one patient had histological evi-
dence of a mild Barrett’s metaplasia. Aperistalsis of the
oesophageal body (>35% non-propelling waves) was
present in 25 patients (71.4%), 10 patients (28.6%) had less
than 35% of non-propelling contractions including one
with vigorous achalasia (hypertonic non-propelling con-
tractions). The mean LES resting pressure was 27.1 mmHg
(range 24–36 mmHg). Eight patients (22.8%) had complete
absence of LES relaxation, 21 patients (60%) had <50%
LES relaxation from their baseline value, and six patients
(17.1%) had >50% LES relaxation. In one patient the probe
did not pass the LES. Medical treatment was attempted in
26 patients (74.3%) before operation, including proton
pump inhibitor (PPI), prokinetic, anxiolytic, and dinitrate,
without any clinic improvement. Eleven patients (5/A–6/B)
(22%) underwent oesophageal pneumatic dilation with a 30
mm Rigiflex balloon (10 psi/30’’/three times); four patients
(2/A–2/B) had botox injections. The success rate was
23.5%, which means that four patients (2/A–2/B), includ-
ing the stage –4 patient, were still satisfied at the control
(18–36 months) and did not accept further treatment.
Thirty-one patients (18A–13B) underwent laparoscopic
Heller–Dor myotomy using a standard technique with five
trocars, a median minimal open access above the umbili-
cus, and a 30 laparoscope, preserving the attachments of
the oesophagus to the crura, and dissecting the muscle
layers with a myotomy of 7–9cm (2–2.5cm on the gastric
side) with plain scissors or ultrasound harmonic scalpel,
carefully ensuring that inactive blade was in contact with
the inner layer, and with gentle distraction of the fibers
Table 1 Patients’ demographics (1996–2004) 35 pts. 14# - 21$
symptoms duration 8–180 months
Group A <70 yrs
(31–68)
20 pts
B >70 yrs
(70–83)
15 pts
Stage 1: <40 mm 3 pts 1 pts
Stage 2: 40–60 mm 8 pts 5 pts
Stage 3:  60 mm 9 pts 8 pts
Stage 4: sigmoid - 1 pts
Other therapies
(11 dilat./4 botox)
A1
nil:12
A2
yes:8
B1
nil:8
B2
yes:7
Comorbidity
Hiatal hernia 1 pt 1 pt
Barrett - 1 pt
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under endoscopic control. The anterior gastric valve was
fixed with 2–3 stitches to both edges of the myotomy. After
surgery they were followed up in the outpatient clinic and
we refer the results of a follow-up of 24–72 months
(median 49) including a complete clinical evaluation at six
and 12 months and then every year, a manometry and pH-
metry and a radiographic study at six, 24, and 60 months.
Quality-of-life assessment
Health-related QoL was assessed with the GIQLI [8], pre-
operatively and then systematically every year. The GIQLI
explores the patient’s self-evaluation of the two-week period
before the questionnaire is filled out. It includes 36 items
covering four domains: gastrointestinal symptoms (19
questions), physical function (seven questions), social
function (four questions), emotional function (five ques-
tions), and one item about subjective treatment assessment.
Every item is scored from 0 (least desirable option) to 4 (most
desirable option), the sum of the GIQLI score ranges from 0
to 144 and in a healthy control population scored 125.8
points (95% confidence interval: 121.5–127.5) [8].
Questions relating to achalasia included: item 27,
exploring regurgitation (‘‘How often during the past two
weeks have you had trouble with fluid or food coming up
into your mouth?’’); item 29 exploring dysphagia (‘‘How
often during the past 2 weeks have you had trouble swal-
lowing your food?’’), item 35 exploring heartburn (‘‘How
often during the past 2 weeks have you had trouble with
heartburn?’’). Other items related to achalasia included
item 1 concerning abdominal pain, item 28 concerning the
speed of eating and item 5 relating to the frequency of
burping and belching.
Statistical analysis
The results are expressed as means ± standard deviation
(SD) of the mean or median (range), as appropriate. The
Mann–Whitney U test, Wilcoxon signed rank test, and
Spearman’s q coefficient for bivariate correlations were
used to compare each item before surgery and at follow-up.
A binary logistic regression model has been applied in
order to analyse the influence of age and previous con-
servative treatment as independent variables on surgical
outcome. p values < 0.05 were considered significant.
Results
As far as surgery is concerned there was one conversion to
laparotomy due to sticky multiple adhesions from previous
abdominal surgery. In two patients with hiatal hernia a
hiatoplasty was carried out; in one patient a cholecystec-
tomy was associated. The median operative time was 110
minutes (range 70–210 mins) and the median postoperative
hospital stay was 4.5 days (range 3–14 days). Intraopera-
tive complications occurred in four patients (2A–2B)
(13%). Two oesophageal mucosal perforations were
sutured immediately with an uneventful postoperative
course. One splenic capsule tear was treated conserva-
tively. One postoperative abdominal bleeding required a
blood transfusion without reoperation. Other postoperative
complications were: pneumonia, superficial wound
haematoma, and urine infection. Operative mortality was
nil. The postoperative instrumental follow-up ranges from
24 to 72 months (median 49), with one patient lost because
of a car accident. Details of the functional results referred
to the main symptoms are reported in Table 2 and reflect
the short- and long-term results of the performed manom-
etry (Table 3) and pH-metry, (Table 4).
Clinic assessment showed that dysphagia was efficiently
treated in 25 patients (15/A–7/B) (80.6%): 16 patients had
no residual episodes of dysphagia, five patients had only
rare episodes (<1 per week), and four had occasional (>1
per week) during the two weeks preceding the evaluation.
Five patients (16.1%) were improved but still had some
degrees of dysphagia during most or all of their meals.
Regurgitation persisted in four patients (16.7%) (frequently
in two patients and most of the time in two patients).
Significant heartburn (most of the time) was reported by
four patients (13%) and they took antacids, as did nine
patients preoperatively. Mild upper-abdominal pain was
reported by five patients (18%). Chest pain more often than
once per week was reported by two patients (6%), who
referred daily chest pain preoperatively. Four patients
complained of occasional chest pain (13.3%). Only one
patient noted some respiratory distress, as they had done
preoperatively. The compared results by age and previous
treatments evidences a significant difference between the
Table 2 Heller–Dor myotomy: functional outcome
Short term Long term
Excellent-good
Our experience 84% 77%
Literature [6,12] 85–95% 48–80%
Gastroesophageal
reflux disease (GERD)
Our experience 15% 13%
Literature 2–7% 17–28%
Dysphagia
Our experience 10% 16.1%
Literature 4–7% 13–22%
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untreated and treated subgroups as far as dysphagia is
concerned at the postoperative control (q = 0.58,
p < 0.05). At five-year follow-up the results have largely
converged (Table 5). A further evaluation of the two main
variables by a binary logistic regression model, coding age
as <70 years and >70 years, and the previous conservative
therapy as independent variables and the abatement (yes/
no) of the dysphagia symptoms after the laparoscopic
procedure as dependent variable, did not highlight any
significant effect, p > 0.05.
Figure 1 shows the comparison between overall preop-
erative and postoperative responses to the GIQLI
questionnaire, distributed in four domains. The median GI-
QLI score at follow-up was 115 points (range 71–140) and
was significantly higher than the preoperative score of 78
(range 38–109) (p < 0.0001). Significantly higher subtotals
were found at follow-up for each domain: symptoms
(p < 0.0001), physical function (p < 0.0001), social func-
tion (p < 0.001), and emotional function (p < 0.001) as well
as for subjective treatment assessment (item 24, p < 0.005),
(Table 6). The analysis shows an improvement at follow-up
in the patients with the preoperative lower scores, and
convergence in the two groups with no significant differ-
ences as far as the age of the patients was concerned.
Oesophageal forceful pneumatic dilation did not affect sur-
gical outcome or the GIQLI score, even in the two patients
with intraoperative mucosal tears. Patients over 70 years old,
however, tended to have more-pessimistic criteria of self-
assessment as far as social life and overall outcome of sur-
gery were concerned, as reported in Table 7.
Discussion
Idiopathic achalasia is a disease that can be palliated but not
cured, which is why symptoms are generally managed with
medical therapy for a long time before taking the decision to
inhibit or cut the LES fibers. The indication to treat patients
who are very poor operative risks with conservative endo-
scopic procedures, either botulinum toxin or endoscopic
pneumatic dilation, should lead us to analyze series of
patients with oesophageal achalasia who have undergone
surgical laparoscopic treatment retrospectively with the aim
of answering the question: should preoperative conservative
Table 3 Manometric features
Group A Group B
Preop Postop* 5 yrs.** Preop Postop* 5 yrs.**
Percentage of aperistaltic waves
 35 72% 11% 6% 69% 8% 4%
 20 22% 22% 16% 31% 25% 20%
< 20 5% 67% 78% – 69% 76%
* p < 0.0001 * p < 0.0001
LES mean
rest. press
27.1 mmHg 10.7 mmHg 11.4 25.8 mmHg 11.5 mmHg 12.6
P < 0.0001 P < 0.0001
LES relaxation
Absent 22% – – 15% – –
<50% 61% 12% 17% 70% 15% 15%
>50% 17% 88% 83% 15% 85% 85%
** 23/31pts
Table 4 pH-metric 24-hour data
Normal mean
value
Group A Group B
Preop Postop 5 yrs Preop Postop 5 yrs
Total 1.82 2.6 + 0.65 18.53 + 10.3 16.4 ± 1.71 2.93 ± 0.6 20.5 + 9.4 14.6 ± 2.5
Upright % Time pH<4 1.5 2.5 ± 0.46 11.9 ± 4.7 7.5 + 1.7 2.75 ± 0.5 13.7 ± 12.8 8.2 ± 3.4
Supine % Time pH<4 1.3 1.7 ± 0.1 13.7 ± 11.2 11.4 ± 2.6 1.5 ± 0.2 14.1 ± 10.7 11.5 ± 5.7
Total no. of episodes 37 25.2 + 4.3 42 ± 20.6 33.3 ± 12.4 26.1 ± 3.9 39 ± 13.5 31.7 ± 7.9
Episodes >5 minutes 0.9 1.8 ± 0.8 9.2 ± 4.2 7.4 ± 3.9 1.6 ± 0.3 10.2 ± 4.2 6.4 ± 2
Longest episode 6.8 4.5 ± 3.3 22 + 11 9.8 ± 4 7.5 ± 3.8 27 ± 12 9.5 ± 3.6
2020 Surg Endosc (2007) 21:2017–2023
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therapy and age greater than 70 be predictive factors that
should influence therapeutical strategy? It is widely accepted
that the majority of patients should be treated by the modality
that appears to warrant a combination of low initial mor-
bidity, high success rate and good long-term outcome.
Pneumatic dilatation and surgical myotomy improve dys-
phagia in the short term in a high percentage of patients [9],
but beyond five to 10 years, only 26 to 49% of patients after
pneumatic dilatation [1, 10, 11] versus 33 to 79% after sur-
gical myotomy [1, 6, 10, 12] are free from dysphagia.
However, 33 to 38% of patients with recurrent dysphagia
manage symptoms without any medical help [10]. Accord-
ing to the only available prospective randomized study of
surgical myotomy with pneumatic dilation [1], myotomy is
more efficient for the treatment of dysphagia at five year
follow-up. Controversy over the best treatment continues, as
both the endoscopic and surgical techniques have evolved.
From the early 1990s, Heller myotomy has been performed
using a transthoracic or transabdominal mini-invasive
approach [13]. Laparoscopy became the technique of choice
as it has the same short-term efficiency for the treatment of
dysphagia as open cardiomyotomy while reducing overall
morbidity [2, 5], and to date, long-term outcome also seems
to be very good [6, 14]. In most retrospective surgical and
endoscopic series, outcome assessment has been based on a
variety of symptom scores that evaluate the main symptoms
of achalasia (e.g., dysphagia, regurgitation or heartburn), so
that the different criteria used do not allow reliable com-
parison. The physical, psychological, and social
consequences of these symptoms, and hence the QoL
impairment they produce, should be evaluated. So, in the
preoperative patient assessment and postoperative analysis
of the outcome of the therapy we applied the gastroentero-
logical self-questionnaires of QoL GIQLI score, in
association with instrumental tests of oesophageal functions.
The present study population is homogeneous, as patients
had the same operative technique and all operations were
performed by the same team of surgeons. Follow-up can be
considered long term with an acceptable median of 42
months. According to the literature [15, 16], a minimum
interval of six months was used between surgery and QoL
evaluation to exclude potential interference of immediate
postsurgical sequelae on QoL. The comparison between
results of the instrumental control and the self-assessment
questionnaire shows substantial overlap and validates the
literature reports on the better long-term outcome of the
laparoscopic Heller–Dor procedure versus conservative
therapies [17]. This study also shows that patients undergo-
ing surgical myotomy have a similar favorable outcome
independent of age and previous treatment. In the patients
included in this study, there was no evidence that repeated
dilations render surgery more difficult even if mucosal tears
occurred in patients who have undergone previous
treatments.
Conclusions
Our results confirm that laparoscopic Heller–Dor myotomy
reaches a functional recovery of the oesophageal function
in about 80% of the patients regardless of age and previous
treatments; these factors regarded either alone or together
Table 5 Symptoms’ clinic
evaluation: not treated vs.
treated patients
NIL Previous treatment*
Preop Postop 5 yrs Preop Postop 5 yrs
Dysphagia
Nil – 79% 74% – 62% 66%
Mild 15% 15% 20% 10% 19% 20%
Moderate 25% 7% 7% 27% 12% 7%
Severe 60% – – 64% 7% 7%
*q = 0.58 p < 0.05 *q = 0.16 n.s.
Heartburn 35% 14% 8% 27% 22% 11%
Regurgitation 65% 21% 10% 63% 18% 10%
Abdominal pain 25% 13% 6% 28% 8% –
* q = 0.17–0.25 n.s.
Fig. 1 Pre- and postoperative gastrointestinal quality-of-life index
(GIQLI)
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do not significantly affect the clinical results of the surgical
procedure, which are correlated, yet not significantly, to the
levels of preoperative scores. The long-term follow-up
(median 49 months) allows us to draw definitive conclu-
sions about the overall positive functional and clinical
outcome with residual pathologic symptoms in about 20%
of patients including the incidence of 13% of reflux and
symptoms correlated (heartburn and chest pain), which
could be considered an expected consequence of myotomy
and are easily controlled by therapy. These results confirm
that the Heller procedure does not need an association with
360 or 270 fundoplication, provided that the dissection is
limited to the anterior oesophagus. Laparoscopic surgery
seems to be the treatment of choice for achalasia either as a
primary or secondary procedure. These results indicate that
health-related QoL is significantly improved in all the
domains tested: symptoms, physical function, social, and
emotional function. Indeed the median postoperative GI-
QLI score of 115 is close to the 95% confidence intervals
of the GIQLI for a healthy control population, while no
significant difference at long-term evaluation was identi-
fied between the two age groups or subgroups used in this
study. Only two patients at the four- and five-year controls
showed a decreasing GIQLI score, confirming that the
postoperative outcome settles down within the first 12–18
months as reported in the literature [6].
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